Associated Papers
[Hereditary prostate cancer].
Heise M et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2014
[Molecular basis of hereditary hemochromatosis].
Romanowski T et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2006
The missense mutations in the candidate prostate cancer gene ELAC2 do not alter enzymatic properties of its product.
Minagawa A et al.
Cancer Letters, 2005
Characterization of TRZ1, a yeast homolog of the human candidate prostate cancer susceptibility gene ELAC2 encoding tRNase Z.
Chen Y et al.
Bmc Molecular Biology, 2005
Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer.
Camp NJ et al.
Genetic Epidemiology, 2005
Prostate cancer susceptibility genes: lessons learned and challenges posed.
Simard J et al.
Endocrine-related Cancer, 2003
A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.
Takaku H et al.
Nucleic Acids Research, 2003
The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex.
Korver W et al.
International Journal of Cancer, 2003
Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.
Camp NJ et al.
American Journal of Human Genetics, 2002
HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.
Meitz JC et al.
British Journal of Cancer, 2002
Perspective: prostate cancer susceptibility genes.
Simard J et al.
Endocrinology, 2002
Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.
Fujiwara H et al.
Journal of Human Genetics, 2002
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Rökman A et al.
Cancer Research, 2001
A candidate prostate cancer susceptibility gene at chromosome 17p.
Tavtigian SV et al.
Nature Genetics, 2001
Select a paper to view details